Graft Versus Host Disease of the Brain Following Allogeneic Stem Cell
Transplant for Myelodysplastic Syndrome
Janet Yoo, M.D. , Lindsay Simon, M.D., Zi-Xuan Wang, Ph.D., and Lawrence C. Kenyon, M.D., Ph.D.
Department of Pathology, Thomas Jefferson University, Philadelphia, PA

Tissue

ABSTRACT
Graft-versus-host disease (GVHD) is a frequent cause of morbidity and
mortality following bone marrow transplantation (BMT). GVHD, which can
present either acutely or chronically, typically involves the skin, gastrointestinal
tract, and liver. In contrast, GVHD involving other organs such as the heart and
kidney is highly uncommon and involvement of the central nervous system has
only rarely been described in the literature. We report an unusual case of
GVHD that involved the heart, kidney, adrenals, and the brain of a recipient of a
dual haploidentical stem cell transplant for myelodysplastic syndrome. Premortem, the patient developed GVHD of the skin and liver. The clinical course
was also complicated by fungal infection (Rhizopus). GVHD of the CNS was
characterized by a lymphocytic leptomeningitis with few perivascular
multinucleated giant cells. Immunohistochemical studies demonstrated both
CD8+ and CD4+ lymphocytes in the leptomeninges and the brain parenchyma
with a marked predominance of CD8+ lymphocytes. CD20 and VZV
immunohistochemistry was negative. Post-mortem PCR analysis of short
tandem repeat (STR) polymorphisms demonstrated a range of ~20-50% of both
donors' lymphocytes in multiple organs. However, due to prolonged formalin
fixation, no PCR signal could be detected in the brain. GVHD of the CNS is rare
and likely underreported due to the declining autopsy rate and a lack of
recognition of the salient histologic features.
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Figure 1: Myocardium: A) Focus of intense inflammation consisting of eosinophils, macrophages
and lymphocytes consistent with GVHD (H&E, 100X). B) Higher magnification demonstrating myocyte
necrosis with associated lymphocytes, eosinophils and macrophages ((H&E, 400X)
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Donor 1 %

Donor 2 %

Brain, Left Hippocampus

ND

ND

Left Kidney

26

25

Right Kidney

24

21

Left Adrenal, Testis

18

18

Bladder and Prostate

14

12

Right Adrenal, Testis

10

12

Heart, Right Ventricle

7

11

Table 1: Percentages of Donor cells in Tissues with GVHD: PCR of short tandem repeat (STR) markers
was used to assess cell populations from donor 1 or donor 2 in 10 μm thick post-mortem paraffin embedded
tissues (Powerplex STR system (Promega, USA)). In some cases, more than one tissue was present per
block. ND (not detected) due to prolonged formalin fixation.
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DISCUSSION
CLINICAL HISTORY, AUTOPSY FINDINGS
The patient was a 55 year old male who presented to Thomas Jefferson
University Hospital for autologous stem cell transplant for treatment of
myelodysplastic syndrome. He received a 2-donor haploidentical stem cell
transplant in August 2011. Bone marrow analysis demonstrated 20% donor 1
and 80% donor 2 engraftment. The hospital course was complicated by cardiac
arrhythmias, renal failure, respiratory failure, an esophagopulmonary fistula and
GVHD of the skin and liver. He was also noted to have episodes of altered
mental status with lethargy and somnolence. CT scans showed no acute
infarcts. No brain MRIs were performed. Premortem testing for BK virus and
CMV was negative.
The significant findings at autopsy included an esophogastric stent perforation
of the stomach and pericardium with rare Rhizopus hyphae and GVHD of the
heart, kidneys, bladder, adrenal glands, and brain. GVHD was most prominent
in the heart (Figure 1).
In other organs, GVHD manifested as variable
(moderate to severe) perivascular and intraparenchymal lymphocytic infiltrates
along with a variable number of histiocytes.

Figure 2: A) Brain, Temporal Lobe (H&E 100X): Perivascular lymphocytes and macrophages with
giant cells. B) Higher magnification (H&E 400X): Multinucleated giant cell arrowed.
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Figure 3: Brain, Hippocampus with Lymphohistiocytic Parenchymal Inflammation.
A) Few lymphocytes can be discerned in the subependymal zone (H&E). B) CD 8+ lymphocytes.
C) CD 4+ lymphocytes (small dark cells) and microglia (extended cells). D) CD 68+ microglia.
All images 100X.

GVHD occurs when transplanted immune cells from a non-identical donor (the
graft) recognize the transplant recipient (the host) as foreign, thereby initiating
an immune response. GVHD involving organs other than skin, gastrointestinal
tract and the liver is rare and remains controversial. This patient manifested
GVHD of the skin and liver pre-mortem. However, these were successfully
treated before death. No GVHD of the bowel was identified due to extensive
post-mortem autolysis. GVHD involving the brain is rare. There are a few
reports of post bone marrow transplant patients with MRI evidence of
predominately white matter changes in addition to leptomeningeal and gray
matter changes whose imaging and neurologic status resolved following
corticosteroid therapy. These patients are presumed to have had GVHD of the
CNS. However, histologic confirmation by biopsy or autopsy is quite rare. The
characteristic histology of donor inflammatory cell damage in multiple organs is
strongly supportive of GVHD in this patient. Furthermore, the pattern of a
perivascular and subendothelial lymphohistiocytic inflammatory infiltration of
cerebral vessels matches earlier descriptions of patients with brain involvement
by GVHD. There was no evidence of a viral cytopathic effect nor were there
any microglial nodules. Immunohistochemistry for VZV was also negative. In
addition, some reports have also identified a predominately intraparenchymal
CD8+ lymphocyte population as described here. One unusual feature in this
patient is the short interval (< 3 months) between engraftment and CNS GVHD.
Most other reports describe several months to years prior to the onset of CNS
symptoms. This discrepancy is likely due to the overall short survival of this
patient. The lack of donor cell DNA in the brain by PCR is a reflection of
prolonged formalin fixation (several weeks). GVHD of the CNS is rare and
treatable. The lack of awareness of this unusual entity is partly due to a
declining autopsy rate, particularly in post bone marrow transplant recipients,
and a lack of recognition by pathologists.

